BioCentury | Mar 30, 2021
Deals

Deerfield’s growing umbrella: Data Byte

...Pharmaceutical Co. Ltd. (Tokyo:4502) and Bay City Capital to support pre-IND stage compounds developed by Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Jun 4, 2019
Distillery Techniques

Tool compounds for probing the role of human cGAS in inflammatory diseases

...L. et al. Nat. Commun. ; published online May 21, 2019 doi:10.1038/s41467-019-08620-4 CONTACT: Daisuke Tomita, Tri-Institutional Therapeutics Discovery Institute...
...RNA Molecular Biology, The Rockefeller University, New York, N.Y. email: ttuschl@rockefeller.edu Sandi Wong Memorial Sloan Kettering Cancer Center Tri-Institutional Therapeutics Discovery Institute The...
BioCentury | Jun 7, 2018
Finance

Deerfield goes to school

...City Capital, that provides financial, operational and managerial support to pre-IND stage compounds developed by Tri-Institutional Therapeutics Discovery Institute...
...Evanston, Ill. The Rockefeller University, New York, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tri-Institutional Therapeutics Discovery Institute...
...Co. Johns Hopkins University Johnson & Johnson Johnson & Johnson Innovation Memorial Sloan Kettering Cancer Center Northwestern University OrbiMed Advisors The Rockefeller University Tri-Institutional Therapeutics Discovery Institute University...
BioCentury | Oct 19, 2017
Finance

Broad umbrella

...Memorial Sloan Kettering Cancer Center , The Rockefeller University , Weill Cornell Medical College , Tri-Institutional Therapeutics Discovery Institute...
...Capital , and provides financial, operational and managerial support to pre-IND stage compounds developed by Tri-Institutional Therapeutics Discovery Institute...
...Therapeutics Inc., Scarsdale, N.Y. Stanford University, Stanford, Calif. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Jan 20, 2017
Company News

Ablexis, Tri-Institutional Therapeutics Discovery Institute deal

...Ablexis LLC , San Francisco, Calif. Tri-Institutional Therapeutics Discovery Institute , New York, N.Y. Business: Functional genomics Alicia Parker Ablexis LLC Tri-Institutional Therapeutics Discovery Institute AlivaMab...
BioCentury | Nov 4, 2016
Company News

Takeda, MSKCC, Rockefeller and Weill deal

...launched Bridge Medicines, a drug discovery company designed to advance candidates developed at the partners' Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Nov 2, 2016
Company News

N.Y. research group, Takeda launch newco Bridge

...launched Bridge Medicines, a drug discovery company designed to advance candidates developed at the partners' Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Feb 4, 2016
Finance

PPP tipping point

...of the key stakeholders to think that way." Purely academic? Michael Foley, director of the Tri-Institutional Therapeutics Discovery Institute...
BioCentury | May 29, 2014
Strategy

New York's biotech beginnings

...a $15 million gift and Howard and Abby Milstein gave $5 million to help found Tri-Institutional Therapeutics Discovery Institute...
...France SUNY Downstate Medical Center , Brooklyn, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tri-Institutional Therapeutics Discovery Institute...
...Milstein Memorial Sloan Kettering Cancer Center (MSKCC); The Rockefeller University; Weill Cornell Medical College Multiple Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Feb 20, 2014
Cover Story

Europe's upwelling

...Memorial Sloan Kettering Cancer Center , The Rockefeller University and Weill Cornell Medical College formed Tri-Institutional Therapeutics Discovery Institute...
...U.K. The Rockefeller University , New York, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tri-Institutional Therapeutics Discovery Institute...
Items per page:
1 - 10 of 13
BioCentury | Mar 30, 2021
Deals

Deerfield’s growing umbrella: Data Byte

...Pharmaceutical Co. Ltd. (Tokyo:4502) and Bay City Capital to support pre-IND stage compounds developed by Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Jun 4, 2019
Distillery Techniques

Tool compounds for probing the role of human cGAS in inflammatory diseases

...L. et al. Nat. Commun. ; published online May 21, 2019 doi:10.1038/s41467-019-08620-4 CONTACT: Daisuke Tomita, Tri-Institutional Therapeutics Discovery Institute...
...RNA Molecular Biology, The Rockefeller University, New York, N.Y. email: ttuschl@rockefeller.edu Sandi Wong Memorial Sloan Kettering Cancer Center Tri-Institutional Therapeutics Discovery Institute The...
BioCentury | Jun 7, 2018
Finance

Deerfield goes to school

...City Capital, that provides financial, operational and managerial support to pre-IND stage compounds developed by Tri-Institutional Therapeutics Discovery Institute...
...Evanston, Ill. The Rockefeller University, New York, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tri-Institutional Therapeutics Discovery Institute...
...Co. Johns Hopkins University Johnson & Johnson Johnson & Johnson Innovation Memorial Sloan Kettering Cancer Center Northwestern University OrbiMed Advisors The Rockefeller University Tri-Institutional Therapeutics Discovery Institute University...
BioCentury | Oct 19, 2017
Finance

Broad umbrella

...Memorial Sloan Kettering Cancer Center , The Rockefeller University , Weill Cornell Medical College , Tri-Institutional Therapeutics Discovery Institute...
...Capital , and provides financial, operational and managerial support to pre-IND stage compounds developed by Tri-Institutional Therapeutics Discovery Institute...
...Therapeutics Inc., Scarsdale, N.Y. Stanford University, Stanford, Calif. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Jan 20, 2017
Company News

Ablexis, Tri-Institutional Therapeutics Discovery Institute deal

...Ablexis LLC , San Francisco, Calif. Tri-Institutional Therapeutics Discovery Institute , New York, N.Y. Business: Functional genomics Alicia Parker Ablexis LLC Tri-Institutional Therapeutics Discovery Institute AlivaMab...
BioCentury | Nov 4, 2016
Company News

Takeda, MSKCC, Rockefeller and Weill deal

...launched Bridge Medicines, a drug discovery company designed to advance candidates developed at the partners' Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Nov 2, 2016
Company News

N.Y. research group, Takeda launch newco Bridge

...launched Bridge Medicines, a drug discovery company designed to advance candidates developed at the partners' Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Feb 4, 2016
Finance

PPP tipping point

...of the key stakeholders to think that way." Purely academic? Michael Foley, director of the Tri-Institutional Therapeutics Discovery Institute...
BioCentury | May 29, 2014
Strategy

New York's biotech beginnings

...a $15 million gift and Howard and Abby Milstein gave $5 million to help found Tri-Institutional Therapeutics Discovery Institute...
...France SUNY Downstate Medical Center , Brooklyn, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tri-Institutional Therapeutics Discovery Institute...
...Milstein Memorial Sloan Kettering Cancer Center (MSKCC); The Rockefeller University; Weill Cornell Medical College Multiple Tri-Institutional Therapeutics Discovery Institute...
BioCentury | Feb 20, 2014
Cover Story

Europe's upwelling

...Memorial Sloan Kettering Cancer Center , The Rockefeller University and Weill Cornell Medical College formed Tri-Institutional Therapeutics Discovery Institute...
...U.K. The Rockefeller University , New York, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tri-Institutional Therapeutics Discovery Institute...
Items per page:
1 - 10 of 13